12 Eylül 2026, Cumartesi · 03:30 Piyasalar Kapalı
borsapanel.com Borsanın nabzı, tek panelde.
Abone Ol

Is AMETEK Stock Outperforming the S&P 500?

Is AMETEK Stock Outperforming the S&P 500?

Neha Panjwani

Thu, September 10, 2026 at 4:33 PM GMT+3 3 min read

Ametek website homepage By Casimiro

Berwyn, Pennsylvania-based AMETEK, Inc. (AME) manufactures and sells electronic instruments and electromechanical devices. Valued at $54.2 billion by market cap, the company manufactures advanced instruments for process, aerospace, power, and industrial markets, and is a supplier of electrical interconnects, specialty metals, technical motors and systems, and floor care and specialty motors.

Companies worth $10 billion or more are generally described as "large-cap stocks," and AME perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the specialty industrial machinery industry. AME's niche focus on electronic and electromechanical products is paying off, with strong market share in aerospace, medical, and industrial sectors. The company's commitment to R&D and innovation has led to a steady stream of new products, leveraging tech like AI and Design for Six Sigma.

More News from Barchart

Despite its notable strength, AME slipped 9.5% from its 52-week high of $261.16, achieved on Aug. 13. Over the past three months, AME stock has gained 2.8%, underperforming the S&P 500 Index's ($SPX) 3.4% gains during the same time frame.

www.barchart.com

Shares of AME rose 15.1% on a YTD basis and climbed 26% over the past 52 weeks, outperforming SPX's YTD gains of 11.6% and 17.3% returns over the last year.

To confirm the bullish trend, AME has been trading above its 200-day moving average over the past year, experiencing a minor fluctuation. However, the stock has been trading below its 50-day moving average since late August.

www.barchart.com

AMETEK outperformed on strong Q2 results driven by broad demand in semiconductor, aerospace, and MedTech. CEO David Zapico cited "double-digit organic sales growth," record orders up 25%, and a $4.1 billion backlog, with about 80% expected to ship in the next 12 months. Electronic Instruments benefited from AI-driven semiconductor equipment and power solutions, while Electromechanical saw MedTech and automation strength. Management raised full-year guidance, pointing to AI, defense, and power grid modernization as durable drivers. M&A remains key, with the pending Indicor deal and FARO integration set to boost growth and margins.

On Aug. 4, AME shares closed up more than 4% after reporting its Q2 results. Its adjusted EPS of $2.09 exceeded Wall Street expectations of $1.99. The company's revenue was $2.04 billion, beating Wall Street forecasts of $1.96 billion. AME expects full-year adjusted EPS in the range of $8.20 to $8.30.

In the competitive arena of specialty industrial machinery, Eaton Corporation plc (ETN) has taken the lead over AME, showing resilience with a 30.4% uptick on a YTD basis, but lagged behind the stock with 19.2% gains over the past 52 weeks.

Wall Street analysts are reasonably bullish on AME's prospects. The stock has a consensus "Moderate Buy" rating from the 21 analysts covering it, and the mean price target of $274.89 suggests a 16.3% potential upside from current price levels.

On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com

Kaynak: Yahoo Finance
İlgili Haberler
Global US judge blocks Trump administration’s ’loyalty’ question for job applicants Investing.com · 12 dk önce Global DocuSign director Peter Solvik sells $3.0 million in stock Investing.com · 14 dk önce Global RingCentral CAO Tarun Arora sells $293,549 in shares Investing.com · 14 dk önce Global Cytokinetics director Robert Landry sells $74,660 in shares Investing.com · 14 dk önce Global Cathie Wood’s ARK sells Twist Bioscience stock, buys more Intellia Investing.com · 18 dk önce

Yorumlar (0)

Giriş yaparak yorum yazabilirsin.

İlk yorumu sen yaz.